LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Tumor immunotherapy - A lot to learn from Keratoacanthoma.

Photo from wikipedia

Dysfunctionalinty and exhaustion of T cells in the tumor microenvironment is a harsh reality of anti-tumor immune response where tumor cells can escape it. A considerable effort is going on… Click to show full abstract

Dysfunctionalinty and exhaustion of T cells in the tumor microenvironment is a harsh reality of anti-tumor immune response where tumor cells can escape it. A considerable effort is going on in the field of research that tries to harness the power of T cells against cancer cells to design new anti-cancer immunotherapeutic designs. All these efforts are getting a setback due to the fact that T cells become dysfunctional in tumors while expressing exhaustion markers, so it is necessary to understand from the perspective of cancer itself that what is lacking in tumor-specific T cells in tumor microenvironment so they are getting evaded. Keratoacanthoma is a compelling case of a tumor where auto-regression is happening and many molecular mechanisms can be attributed to this fact. One of the possibilities is having non-exhausting T cells and a highly conducive environment for anti-tumor immune response. In this hypothesis, I am proposing a detailed strategy to decipher this peculiar type of possible immune response in keratoacanthoma and how it can be idolized to create successful anti-cancer T cell immunotherapies.

Keywords: tumor immunotherapy; immunotherapy lot; immune response; cancer; lot learn; tumor

Journal Title: Medical hypotheses
Year Published: 2020

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.